EXPIRED

This event
is Finished

Title: World Diabetes Congress Melbourne 2013

Specialty: , Endocrinology, Other Specialties

Dates: From Dec, 2, 2013 to Dec, 6, 2013

Location: Melbourne, AUSTRALIA

Type: Congress

Registration Cost: From 110 to 990 EUR

Event Tools

Add to Favorites

Social Media

Share on Facebook
Share on Linkedin
Share on Twitter
Share on Google+

Add to my Calendar

Scientific Programm
Online registration
Exhibition floorplans
Sponsorship &
Exhibition consensus
Virtual Booths

Dec

Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Melbourne, Australia.

Event Venue:

Melbourne Convention and Exhibition Centre #

Melbourne, AUSTRALIA

Recognised as Australiasia's Leading Meetings and Conference Centre in 2014, 2013 and 2012 by the prestigious World Travel Awards, Melbourne Convention and Exhibition Centre connects you with everything you need for a successful event. This includes amazing spaces, leading technology, creative food and wine and staff with the skills and experience to bring it all together.

Visit the Venue to read more

Currency:

EUR

Welcome message:

WELCOME MESSAGE FROM THE IDF PRESIDENT

The International Diabetes Federation is the global voice for people with diabetes and those at risk. Twenty years after the World Diabetes Congress in Japan, the Western Pacific Region is again in the global health spotlight and is why we have chosen Melbourne to host the World Diabetes Congress in 2013.

Today, more than a third of all people with diabetes are found in the Western Pacific Region. It is also the region that has the highest number of undiagnosed cases and the highest number of deaths attributable to diabetes.

In Australia, 8 per cent of the population is now living with diabetes. This is predicted to increase to 14 per cent over the next twenty years. Indigenous communities in Australia are also a major concern as the prevalence within this population is three to four times higher than the rest of the Australia.

Melbourne will provide a perfect backdrop to inspire global actions anf agreements to act on diabetes and help safeguard the health of future generations.

Melbourne's location also makes the congress easily accessible to delegates from China and India, the two countries with the highest numbers of people with diabetes in the world.

We cordially invite you to join the global diabetes community for the World Diabetes Congress in Melbourne on December 2-6 2013.

Join us in our mission to advance diabetes care, prevention and a cure worldwide.

Sir Michael Hirst
President, International Diabetes Federation 2013-2015

WELCOME MESSAGE FROM THE PREMIER OF VICTORIA

I am delighted to welcome you to Melbourne for the World Diabetes Congress and I am immensely proud to be able to support one of the world’s largest health-related events focused on such an important topic.

The increasing rates of diabetes in countries throughout the world pose significant challenges that are too complex for any person, organization, institution or government to tackle alone. Addressing diabetes needs a collaborative effort across many disciplines and sectors including health professionals, health agencies, scientists, individuals and carers.

Events such as this Congress present an enormous opportunity to come together and share the most recent evidence and best practice to support improvements in diabetes care, treatment and prevention. I am particularly pleased to see that this Congress will include a new stream on Diabetes in Indigenous Peoples.

Victoria is an ideal venue for the Congress, hosting many leading scientific research institutions and becoming increasingly recognised as a world biotechnology hub. I am proud that Melbourne researchers are making a major contribution to efforts globally to find a cure for type 1 diabetes. We also look forward to showcasing some of the activities supported by the Victorian government in diabetes prevention, in addition to learning what is happening in other countries and regions.

I would like to thank the International Diabetes Federation for holding the Congress in Melbourne, and also thank the Congress committees and staff for their commitment and dedication to successfully delivering the World Diabetes Congress. I would also like to acknowledge the important role played by Diabetes Australia in supporting the event.

It is with enthusiasm and encouragement that I welcome you to the Congress. I hope that your attendance supports you to deliver practical solutions to the serious problems associated with diabetes.

I hope your visit to Melbourne is enjoyable and I encourage you to take the time to explore our wonderful city, and Victoria more broadly.

The Hon Dr Denis Napthine MP

Premier

Accommodation:

Arinex Pty Limited are the official housing bureau for the World Diabetes Congress 2013 in Melbourne, Australia.

A large number of rooms in a broad range of categories have been contracted. Congress participants are advised to make reservations as early as possible to secure their preferred hotel category and to obtain the best rates. Most hotels are within walking distance of the congress venue.

Please note:

All rates are quoted in Australian Dollars (AUD)
All rates are quoted per room and per night, inclusive of a non-claimable 10% GST
All quoted rates are valid for standard rooms, subject to hotel availability
Rates for other room types are available upon request, subject to hotel availability.
Rates may fluctuate so please visit the online accommodation booking form to view current room rates plus booking terms and conditions.

Contact

Congress participants are encouraged to make reservation requests online (online reservation will be available soon). For further assistance please contact the congress housing bureau:

World Diabetes Congress Melbourne 2013 Accommodation Managers
Arinex Pty Limited
T: + 61 (2) 9265 0700
Fax: + 61 (2) 9267 5443
E: wdc2013@arinex.com.au

Submission Info

Late-breaking abstract submission will be allowed for authors to submit their breakthrough findings in the field of diabetes.

Authors should ONLY submit abstracts which comply with the following conditions:

They should contain new research findings of special importance
They Should NOT contain preliminary data
Results published or likely to have been published before 6 December 2013 are not allowed.

Poster

Editorial Guidelines for Presented Content:

Submission mode: Late-breaking abstract submission is only possible online atwww.worlddiabetescongress.org. Abstracts submitted by post, fax or email will NOT be accepted. The online abstract submission module will NOT be available after 16 August 2013, 17.00 Greenwich Mean Time (GMT).

IDF Congress Profile: In order to submit an abstract, a congress profile must be created to register for the congress and allowing entry into the online abstract submission module. The presenting author must ensure accurate contact details are entered. One or several abstracts can be submitted by logging into this congress profile.

Submitting author / Presenting author: The submitting author must be the presenting author. The presenting author must be registered before submitting a late-breaking abstract. If the presenting author is not registered their abstract will not be sent to the Programme Committee for review.

Number of submissions: There can only be ONE presenting author per abstract. The same abstract CANNOT be submitted multiple times by listing different presenting authors. An unlimited number of abstracts can be submitted and presented by an individual.

Language: All abstracts must be submitted in English. Should English not be your first language, you may wish to have your abstract examined by a native English speaker prior to submission.

Accuracy of content: Submitted abstracts may be edited online prior to the abstract submission deadline: 16 August 2013, 17.00 Greenwich Mean Time (GMT). Abstracts CANNOT be edited or revised in any way after the deadline. All accepted abstracts will be published as submitted by the author. The responsibility for the submission of an accurate and precise abstract lies solely with the author.

Originality of abstracts: Work published elsewhere before 6 December 2013 should NOT be resubmitted to the World Diabetes Congress. However, previously published work can be resubmitted provided there are new methods and/or findings.

Disclosure of interests: Any financial relationships with commercial entities in the products or processes described in the work must be correctly stated.

Regulatory approval: The presenting author confirms that local regulatory approval has been obtained as required by local laws.

Author consent: The presenting author declares all authors have read and approved the submitted work.

Copyright transfer: Authors must attest that their submitted work does not infringe any copyright legislation. Copyright for the publication of abstracts is automatically transferred to the International Diabetes Federation upon submission and acceptance of the regulations within the online submission module. For rejected abstracts, the copyright reverts back to the authors.

INSTRUCTIONS

Category and stream: There are various categories that have been defined for the abstract programme along with five streams. Ensure that you select the MOST relevant stream and then select the ONE category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes.

Abstract title:

The title is limited to 120 characters excluding spaces and should be brief and relevant. Special characters should NOT be used in your title but spelt out instead (e.g. ß is beta; ω is omega).
Only use standard abbreviations and generic drug names in the title.

Authors: Only 12 authors and/or study groups can be listed. Only one institution can be entered per author.

Abstract body:

Structure: the abstract, if applicable, to include aims, methods, results and discussion/conclusion.
Font, size and style will be automatically configured by the system.
Tables will be accepted in the submission field and count towards the character limit. The character deduction for tables is not fixed and will be generated by the character count shown below the submission field. Graphs, figures and photographs are NOT allowed.
The length of the abstract is limited to 2100 characters excluding spaces. Only the abstract body and any inserted tables count towards the character limit. The character count displayed beneath the submission field is final and undisputable.
Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Treatment groups or drug names should NOT be abbreviated. Less widely recognized abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
Only approved and generic (non-proprietary) drug names should be used.
Do NOT enter the title, authors, or grant information into the abstract text submission field and exclude any references from the abstract body.

SELECTION AND NOTIFICATION PROCESS

Selection: All submitted late-breaking abstracts are reviewed by the Programme Committee. The Programme Committee reserves the right to accept or reject any submitted abstract and re-categorize any accepted abstract. The decision of the Programme Committee is final and irrevocable.
Notification: Notice of acceptance or rejection of submitted late-breaking abstracts will be sent to the presenting author by the end of September 2013. It is the responsibility of the presenting author to inform all other authors of the status of the abstract. A presenting author may also check their congress profile to see the status of the abstract.

Organising Agency

All enquiries and correspondence in relation to the World Diabetes Congress should be directed to:

Congress Secretariat - International Diabetes Federation (IDF)
Chaussée de la Hulpe 166
1170 Brussels
Belgium
T: +32 2 5431631
F: +32 2 4030830
E: wdc@idf.org

Official Event Webpage

http://www.idf.org/worlddiabetescongress/welcome